Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 

    Article Cited by others

ORIGINAL ARTICLE

Fucoxanthin attenuates behavior deficits and neuroinflammatory response in 1-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine-induced Parkinson's disease in mice

Sun Guoqing, Xin Tao, Zhang Rui, Liu Chengxiao, Pang Qi

Year : 2020| Volume: 16| Issue : 67 | Page no: 51-56

   This article has been cited by
 
1 Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification
Zhichao Zhong, Xingrui He, Jiamin Ge, Junlong Zhu, Chuansheng Yao, Hong Cai, Xiang-Yang Ye, Tian Xie, Renren Bai
European Journal of Medicinal Chemistry. 2022; : 114378
[Pubmed]  [Google Scholar] [DOI]
2 Advances in fucoxanthin chemistry and management of neurodegenerative diseases
Na Li, Xiaoxiang Gao, Lingjun Zheng, Qihui Huang, Feng Zeng, Hongbin Chen, Mohamed A. Farag, Chao Zhao
Phytomedicine. 2022; : 154352
[Pubmed]  [Google Scholar] [DOI]
3 Fucoxanthin from Algae to Human, an Extraordinary BioreSource: Insights and Advances in up and Downstream Processes
Anne Pajot, Gia Hao Huynh, Laurent Picot, Luc Marchal, Elodie Nicolau
Marine Drugs. 2022; 20(4): 222
[Pubmed]  [Google Scholar] [DOI]
4 Fucoxanthin has potential for therapeutic efficacy in neurodegenerative disorders by acting on multiple targets
Mengxiang Yang, Zhenquan Xuan, Qiyao Wang, Sicheng Yan, Dongsheng Zhou, C. Benjamin Naman, Jinrong Zhang, Shan He, Xiaojun Yan, Wei Cui
Nutritional Neuroscience. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article